← Leaderboards
Lincoln Paul Edwards
Loma Linda University
$785,599
Attributed
$785,599
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $446K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$785,599 · 3
By mechanism
R15$446,047 · 1
R03$324,000 · 1
P20$15,552 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immunoprecipitation”
- Michael P Snyder · Yale University$79,878,429
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$33,683,207
- Alice Telesnitsky · University Of Michigan At Ann Arbor$21,681,930
- Cun-Yu Wang · University Of California Los Angeles$18,408,159
- Mark W Feinberg · Brigham And Women'S Hospital$17,048,437
- Mitchell A. Lazar · University Of Pennsylvania$16,969,892
Research focus
ImmunoprecipitationPhosphatidylinositol 3 KinasePhosphorylationHormone Regulation /Control MechanismReceptor CouplingAntidiabetic DrugsAmericanAdverse EffectsBlood Pressure RegulationBlood PressureBrainBrain RegionCardiovascular SystemCell LineAgonistCoupledCompliance BehaviorBiological Signal TransductionCytokine ReceptorsDiabetes MellitusDiabeticDiabetic PatientDoseClinical Trials
Grant awards (5)
Novel Imidazoline Compound As Antidiabetic Agent$422,333
R15 · FY2011 · DK · contact PI
Novel Imidazoline Compound As Antidiabetic Agent$23,714
R15 · FY2011 · DK · contact PI
The role of imidazoline receptor in type-2 diabetes$15,552
P20 · FY2006 · MD · contact PI
Interactions between Imidazoline and Insulin Receptors$162,000
R03 · FY2005 · DK
Interactions between Imidazoline and Insulin Receptors$162,000
R03 · FY2004 · DK